Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
EDX Medical Group PLC - London-based developer of diagnostics products to help predict disease risk - Started trading on AQSE last week following £12 million reverse takeover by special purpose acquisition company TECC Capital PLC. Raised £1.2 million via placing 20.0 million shares at 6 pence per share. Chair of newly restructured company is Jason Holt, and chief executive officer is Michael Hudson. Chief scientific officer is Christopher Evans. TECC’s former chair Sandy Barblett, and former CEO John Taylor step down from the board.
Current stock price: 5.25 pence for £13.2 million market capitalisation
Copyright 2022 Alliance News Limited. All Rights Reserved.